Late Cardiotoxicity Signals in Survivorship: The Primary-Care Recognition Pattern
Anthracycline, HER2, radiation, and checkpoint-inhibitor cardiotoxicity present quietly years after treatment ends. A recognition pattern, escalation trigger, and referral script for the primary-care clinician now carrying the follow-up.
Cardiotoxicity is not a treatment-era problem. It is a survivorship-era problem that presents in primary-care exam rooms years after the last infusion or the last radiation fraction. The recognition pattern below is what oncology and cardio-oncology colleagues would like every primary-care clinician to have on the wall.
Anthracyclines: late LVEF drift and arrhythmia
Anthracycline cardiotoxicity is dose-dependent but not dose-limited to the classical 450 mg/m² threshold. Late LVEF drift occurs at moderate cumulative doses, particularly with pediatric exposure, chest radiation, or a second cardiotoxic agent.
Recognition pattern: exertional dyspnea, new orthopnea, palpitations, or an incidental ECG finding (LBBB, PVCs) in a survivor with prior anthracycline exposure. Reflex bundle: BNP, troponin, ECG, transthoracic echo with GLS if available.
HER2 therapy: post-treatment LVEF surveillance
Trastuzumab-related cardiac dysfunction is usually reversible in active therapy — and often forgotten in survivorship. A two-year post-treatment echo cadence catches the late drop most primary-care schedules miss.
Radiation: pericardial, valvular, coronary, conduction
Mediastinal or left-chest radiation before the modern era carries a four-lane risk profile that surfaces decades later. Recognition patterns are lane-specific: pericardial friction rub or effusion, new valvular murmur, angina at a lower workload, unexplained conduction abnormality.
Cardio-oncology referral for stress imaging cadence in the third and fourth decades post-radiation is the highest-yield single order.
Immune checkpoint inhibitors: late myocarditis
ICI myocarditis is rare but high-fatality and can present months to a year after the last dose. Any ICI-exposed survivor with unexplained fatigue, dyspnea, chest discomfort, or palpitations gets the reflex bundle same-day and a low-threshold cardiology call.
The referral script
'This is a survivor of [diagnosis] treated with [regimen / cumulative dose / radiation field]. Presenting with [symptom cluster]. I've drawn troponin and BNP and an ECG, and ordered an echo with GLS. I'm asking for a low-threshold cardio-oncology evaluation with a plan for ongoing shared surveillance.' That paragraph, sent through the referral inbox, is what accelerates the visit.
Frequently asked questions
- How late is 'late' for anthracycline cardiotoxicity?
- Late LVEF drift can appear a decade or more after treatment. Any anthracycline exposure earns a lifelong low-threshold reflex to the recognition bundle when symptoms appear.
- Do I need GLS or is a standard echo enough?
- Standard echo is the minimum. GLS increases sensitivity for early subclinical dysfunction and is the preferred cadence measure in cardio-oncology programs; ask for it when available.
- What triggers a same-day ICI myocarditis workup?
- Any ICI-exposed survivor with unexplained fatigue, dyspnea, chest discomfort, palpitations, or a new arrhythmia — regardless of how long ago the last dose was.